Evaluating biomarkers for prognostic enrichment of clinical trials.

about

Plasma biomarkers are associated with renal outcomes in individuals with APOL1 risk variants.Biomarkers of AKI Progression after Pediatric Cardiac Surgery.

P2860

Q52568967-B8F3A71A-9589-4C44-9C68-19FFEBC11E3A Q52689194-C98FA224-DE60-4D3C-ACC9-8F9295AA5523

P2860

Evaluating biomarkers for prognostic enrichment of clinical trials.

Item

http://www.wikidata.org/entity/Q38399183

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Evaluating biomarkers for prognostic enrichment of clinical trials.

@en

type

Item

label

Evaluating biomarkers for prognostic enrichment of clinical trials.

@en

prefLabel

Evaluating biomarkers for prognostic enrichment of clinical trials.

@en

P1476

Evaluating biomarkers for prognostic enrichment of clinical trials.

@en

P2093

Allison Meisner

http://www.w3.org/2001/XMLSchema#string

Chirag R Parikh

http://www.w3.org/2001/XMLSchema#string

Francis Perry Wilson

http://www.w3.org/2001/XMLSchema#string

Heather Thiessen-Philbrook

http://www.w3.org/2001/XMLSchema#string

Jeremy Roth

http://www.w3.org/2001/XMLSchema#string

Kehao Zhu

http://www.w3.org/2001/XMLSchema#string

P2860

Developing risk prediction models for kidney injury and assessing incremental value for novel biomarkers

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study

Postoperative biomarkers predict acute kidney injury and poor outcomes after adult cardiac surgery

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

Who should be included in a clinical trial of screening for bladder cancer?: a decision analysis of data from the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.

Molecular and genetic targets in early detection.

Renal cancer biomarkers: the promise of personalized care

Decision curve analysis: a novel method for evaluating prediction models

P304

629-638

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1740774517723588

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Steven G Coca

M Kathleen Kerr

P577

2017-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28795578

http://www.w3.org/2001/XMLSchema#string

P932

5714681

http://www.w3.org/2001/XMLSchema#string

Evaluating biomarkers for prognostic enrichment of clinical trials.

about

P2860

P2860

Evaluating biomarkers for prognostic enrichment of clinical trials.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932